Clinical trials of reducing low-density lipoprotein concentrations

Endocrinology and Metabolism Clinics of North America

Volumn 27, Issue 3, 1998, Pages 585-595

  Rifkind, B M ^a  

^a Applied Research Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN;

AGE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DIABETES MELLITUS; DRUG EFFECT; DRUG RESEARCH; DRUG SCREENING; DYSLIPOPROTEINEMIA; HUMAN; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0031710947     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70027-X     Document Type: Article

References (33)

1. D.H. Blankenhorn S.A. Nessim R.L. Johnson Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts JAMA 257 1987 3233
2. Brown B.G. Zhao X.-Q. D.E. Sacco Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease Circulation 87 1993 1781
3. W.P. Castelli R.J. Garrison P.W.F. Wilson Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study JAMA 256 1986 2835
4. Consensus Conference Statement on Lowering Blood Cholesterol to Prevent Heart Disease JAMA 253 1985 2080
5. J.R. Crouse R.P. Byington M.G. Bond Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II): A clinical trial with atherosclerosis outcome Am J Cardiol 75 1995 455
6. M.J. Davies A.C. Thomas Plaque fissuring—the cause of acute myocardial infarction, sudden ischemic death and crescendo angina Br Heart J 53 1985 363
7. B.R. Davis J.A. Cutler D.J. Gordon Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Am J Hypertens 9 1996 342
8. Furberg C.D. Adams H.P. Jr W.B. Applegate Effects of lovastatin on early carotid atherosclerosis and cardiovascular events Circulation 90 1994 1679
9. A.M. Garber W.S. Browner Cholesterol screening guidelines: Consensus, evidence and common sense Circulation 95 1997 1642
10. H.N. Hodis Reversibility of atherosclerosis-evolving perspectives from two arterial imaging clinical trials: The Cholesterol Lowering Atherosclerosis Regression Study and the Monitored Atherosclerosis Regression Study J Cardiovasc Pharmacol 25 suppl 4 1995 25
11. S.B. Hulley J.M.B. Walsh T.B. Newman Health policy on blood cholesterol: Time to change directions Circulation 86 1992 1027
12. P.H. Jones A.M. Gotto Extending the benefit of lipid regulating therapy to primary prevention Am J Cardiol 66 1996 118C
13. R.C. Laughlin T.F. Carey Cataracts in patients treated with triparanol JAMA 181 1962 339
14. S.J. Lewis J. Mitchell B.C. East Older patients in CARE benefit from pravastatin test myocardial infarction J Am Coll Cardiol (abstract) 29 1997 375A
15. LIPID Study Investigators Design features and baseline characteristics of the LIPID (Long-term Intervention with Pravastatin in Ischaemic Heart Disease) Study: A randomized trial in patients from Australia and New Zealand with previous myocardial infarction and/or unstable angina Am J Cardiol 76 1995 474
16. Lipid Research Clinics Program The Lipid Research Clinics Coronary Primary Prevention Trial Results I: Reduction in incidence of coronary heart disease JAMA 251 1984 351
17. Lipid Research Clinics Program The Lipid Research Clinics Coronary Primary Prevention Trial Results II: The relationship of reduction in incidence of coronary heart disease to cholesterol lowering JAMA 251 1984 365
18. T.A. Manolio T.A. Pearson N.K. Wenger Cholesterol and heart disease in older persons and women Ann Epidemiol 2 1992 161
19. M.J. Martin S.B. Hulley W.S. Browner Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361,662 men Lancet 2 1986 933
20. M. Mercuri M.G. Bond C.R. Sirtori Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: The Carotid Atherosclerosis Italian Ultrasound Study Am J Med 101 1996 627
21. M.F. Muldoon S.B. Manuck K.A. Matthews Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials BMJ 301 1990 309
22. National Cholesterol Education Program Second report on the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) Circulation 89 1994 1329
23. T.B. Newman S.B. Hulley Carcinogenicity of lipid-lowering drugs JAMA 275 1996 55
24. M.F. Oliver Is cholesterol reduction always safe? Eur J Clin Invest 22 1992 441
25. M.F. Oliver Serum cholesterol: The knave of hearts and the joker Lancet 2 1981 1090
26. K. Pyorala T.R. Pedersen J. Kjekshus Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease Diabetes Care 20 1997 614
27. J.E. Rossouw Lipid-lowering interventions in angiographic trials Am J Cardiol 78 1995 86-C
28. F.M. Sacks M.A. Pfeffer L.A. More The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001
29. R. Salonen K. Nyyssonen E. Porkkala Kuopio Atherosclerosis Prevention Study (KAPS): A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries Circulation 92 1995 1758
30. Scandinavian Simvastatin Survival Study Group Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study Lancet 344 1994 1383
31. J. Shepherd S.M. Cobb I. Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301
32. N. Stone R.I. Levy D.S. Fredrickson Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia Circulation 49 1976 476
33. G.D. Smith G. Pekkanen Should there be a moratorium on the use of cholesterol lowering drugs? BMJ 304 1992 421